# THALOMID
> **NDA020785** · New Drug Application · Sponsor: BRISTOL-MYERS · Approved 1998-07-16
## Drug
- **FDA Application Number:** NDA020785
- **Application type:** New Drug Application
- **Brand name:** THALOMID
- **Generic name:** THALIDOMIDE
- **Active ingredients:** THALIDOMIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** BRISTOL-MYERS
- **Manufacturer:** Celgene Corporation
- **First approval:** 1998-07-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020785)
---
*MORVS · CC0 1.0*